Acella Pharmaceuticals, LLC
NDC labeler code: 42192
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- Brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide2 products
- DoxycyclineDoxy 100, Doryx Mpc, Acticlate Cap · 1 product
- PhenytoinDilantin, Phenytek, Phenytoin Infatabs · 1 product
- BaclofenLyvispah, Gablofen, Baclofen (Intrathecal) · 1 product
- NaproxenNaprelan, Rugby All Day Relief · 1 product
- GabapentinNeurontin, Gralise, Relgaabi · 1 product
- Pyridostigmine bromideMestinon, Pryidostigmine Bromide, Regonol · 1 product
- Ciclopirox1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| April 19, 2022 | ANDA212405 | Pyridostigmine bromide PYRIDOSTIGMINE BROMIDE | Milla Pharms |
| March 16, 2020 | ANDA210664 | Doxycycline DOXYCYCLINE HYCLATE | Acella |
| September 18, 2019 | NDA208193 | Baclofen OZOBAX, OZOBAX DS | Rosemont |
| September 20, 2016 | ANDA203375 | Brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | Acella |
| May 1, 2012 | ANDA076403 | Gabapentin GABAPENTIN | Acella Pharms LLC |
| September 18, 2007 | ANDA078172 | Ciclopirox CICLOPIROX | Acella |
| September 13, 2006 | ANDA040573 | Phenytoin PHENYTOIN SODIUM | Acella |
| March 23, 1987 | NDA018965 | Naproxen NAPROSYN | Atnahs Pharma Us |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2026
-
April 20, 2026 · Class II · Ongoing · D-0523-2026 · Naproxen
Chemical contamination; presence of lead and lithium above specification
NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16
2025
-
September 29, 2025 · Class II · Ongoing · D-0014-2026 · Doxycycline
Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.
Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.
2022
-
November 14, 2022 · Class III · Terminated · D-0070-2023 · Phenytoin
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05, packaged in 10 x 5 mL vials per carton, NDC 42192-614-30, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005
-
November 14, 2022 · Class III · Terminated · D-0069-2023 · Phenytoin
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Phenytoin Sodium Injection, USP 100 mg/2 mL, NDC 42192-614-02, packaged in 10 x 2 mL vials per carton, NDC 42192-614-10, Rx only, Manufactured for: Acella Pharmaceuticals, LLC Alpharetta, GA 30005
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026